Direct Oral Anticoagulants Market Size, Share, Value and Forecast 2034
Direct Oral Anticoagulants Market By Drug Type (Dabigatran, Rivaroxaban, Edoxaban, Apixaban, and Others), By Application (Atrial Fibrillation, Pulmonary Embolism, Deep Vein Thrombosis, and Others), By Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies, and Others), and By Region - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2026 - 2034
Category: Healthcare Report Format : PDF
Pages: 227 Report Code: ZMR-10657
Published Date: Jul-2026 Status : Published
| Market Size in 2025 | Market Forecast in 2034 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 19.8 Billion | USD 41.3 Billion | 8.5% | 2025 |
Table Of Content
- Chapter 1. Preface
- 1.1 Report Description and Scope
- 1.2 Research scope
- 1.3 Research methodology
- 1.3.1 Market Research Type
- 1.3.2 Market research methodology
- Chapter 2. Executive Summary
- 2.1 Global Direct Oral Anticoagulants Market, (2026 - 2034) (USD Billion)
- 2.2 Global Direct Oral Anticoagulants Market : snapshot
- Chapter 3. Global Direct Oral Anticoagulants Market - Industry Analysis
- 3.1 Direct Oral Anticoagulants Market: Market Dynamics
- 3.2 Market Drivers
- 3.2.1 The rising prevalence of atrial fibrillation and venous thromboembolism drive the direct oral anticoagulants market
- 3.3 Market Restraints
- 3.3.1. High treatment costs compared with traditional anticoagulants hamper the growth of the direct oral anticoagulants industry
- 3.4 Market Opportunities
- 3.4.1. The growing partnership among key players offer a lucrative opportunity for the direct oral anticoagulants market
- 3.5 Market Challenges
- 3.5.1. The competition from generic products pose a significant challenge to the direct oral anticoagulants market
- 3.6 Porter’s Five Forces Analysis
- 3.7 Market Attractiveness Analysis
- 3.7.1 Market attractiveness analysis By Drug Type
- 3.7.2 Market attractiveness analysis By Application
- 3.7.3 Market attractiveness analysis By Distribution Channel
- Chapter 4. Global Direct Oral Anticoagulants Market- Competitive Landscape
- 4.1 Company market share analysis
- 4.1.1 Global Direct Oral Anticoagulants Market: company market share, 2025
- 4.2 Strategic development
- 4.2.1 Acquisitions & mergers
- 4.2.2 New Product launches
- 4.2.3 Agreements, partnerships, cullaborations, and joint ventures
- 4.2.4 Research and development and Regional expansion
- 4.3 Price trend analysis
- 4.1 Company market share analysis
- Chapter 5. Global Direct Oral Anticoagulants Market - Drug Type Analysis
- 5.1 Global Direct Oral Anticoagulants Market overview: By Drug Type
- 5.1.1 Global Direct Oral Anticoagulants Market share, By Drug Type, 2025 and 2034
- 5.2 Dabigatran
- 5.2.1 Global Direct Oral Anticoagulants Market by Dabigatran, 2026 - 2034 (USD Billion)
- 5.3 Rivaroxaban
- 5.3.1 Global Direct Oral Anticoagulants Market by Rivaroxaban, 2026 - 2034 (USD Billion)
- 5.4 Edoxaban
- 5.4.1 Global Direct Oral Anticoagulants Market by Edoxaban, 2026 - 2034 (USD Billion)
- 5.5 Apixaban
- 5.5.1 Global Direct Oral Anticoagulants Market by Apixaban, 2026 - 2034 (USD Billion)
- 5.6 Others
- 5.6.1 Global Direct Oral Anticoagulants Market by Others, 2026 - 2034 (USD Billion)
- 5.1 Global Direct Oral Anticoagulants Market overview: By Drug Type
- Chapter 6. Global Direct Oral Anticoagulants Market - Application Analysis
- 6.1 Global Direct Oral Anticoagulants Market overview: By Application
- 6.1.1 Global Direct Oral Anticoagulants Market share, By Application, 2025 and 2034
- 6.2 Atrial Fibrillation
- 6.2.1 Global Direct Oral Anticoagulants Market by Atrial Fibrillation, 2026 - 2034 (USD Billion)
- 6.3 Pulmonary Embolism
- 6.3.1 Global Direct Oral Anticoagulants Market by Pulmonary Embolism, 2026 - 2034 (USD Billion)
- 6.4 Deep Vein Thrombosis
- 6.4.1 Global Direct Oral Anticoagulants Market by Deep Vein Thrombosis, 2026 - 2034 (USD Billion)
- 6.5 Others
- 6.5.1 Global Direct Oral Anticoagulants Market by Others, 2026 - 2034 (USD Billion)
- 6.1 Global Direct Oral Anticoagulants Market overview: By Application
- Chapter 7. Global Direct Oral Anticoagulants Market - Distribution Channel Analysis
- 7.1 Global Direct Oral Anticoagulants Market overview: By Distribution Channel
- 7.1.1 Global Direct Oral Anticoagulants Market share, By Distribution Channel, 2025 and 2034
- 7.2 Hospital Pharmacies
- 7.2.1 Global Direct Oral Anticoagulants Market by Hospital Pharmacies, 2026 - 2034 (USD Billion)
- 7.3 Online Pharmacies
- 7.3.1 Global Direct Oral Anticoagulants Market by Online Pharmacies, 2026 - 2034 (USD Billion)
- 7.4 Others
- 7.4.1 Global Direct Oral Anticoagulants Market by Others, 2026 - 2034 (USD Billion)
- 7.1 Global Direct Oral Anticoagulants Market overview: By Distribution Channel
- Chapter 8. Direct Oral Anticoagulants Market - Regional Analysis
- 8.1 Global Direct Oral Anticoagulants Market Regional Overview
- 8.2 Global Direct Oral Anticoagulants Market Share, by Region, 2025 & 2034 (USD Billion)
- 8.3. North America
- 8.3.1 North America Direct Oral Anticoagulants Market, 2026 - 2034 (USD Billion)
- 8.3.1.1 North America Direct Oral Anticoagulants Market, by Country, 2026 - 2034 (USD Billion)
- 8.3.1 North America Direct Oral Anticoagulants Market, 2026 - 2034 (USD Billion)
- 8.4 North America Direct Oral Anticoagulants Market, by Drug Type, 2026 - 2034
- 8.4.1 North America Direct Oral Anticoagulants Market, by Drug Type, 2026 - 2034 (USD Billion)
- 8.5 North America Direct Oral Anticoagulants Market, by Application, 2026 - 2034
- 8.5.1 North America Direct Oral Anticoagulants Market, by Application, 2026 - 2034 (USD Billion)
- 8.6 North America Direct Oral Anticoagulants Market, by Distribution Channel, 2026 - 2034
- 8.6.1 North America Direct Oral Anticoagulants Market, by Distribution Channel, 2026 - 2034 (USD Billion)
- 8.4. Europe
- 8.4.2 Europe Direct Oral Anticoagulants Market, 2026 - 2034 (USD Billion)
- 8.4.2.1 Europe Direct Oral Anticoagulants Market, by Country, 2026 - 2034 (USD Billion)
- 8.4.2 Europe Direct Oral Anticoagulants Market, 2026 - 2034 (USD Billion)
- 8.4 Europe Direct Oral Anticoagulants Market, by Drug Type, 2026 - 2034
- 8.4.1 Europe Direct Oral Anticoagulants Market, by Drug Type, 2026 - 2034 (USD Billion)
- 8.5 Europe Direct Oral Anticoagulants Market, by Application, 2026 - 2034
- 8.5.1 Europe Direct Oral Anticoagulants Market, by Application, 2026 - 2034 (USD Billion)
- 8.6 Europe Direct Oral Anticoagulants Market, by Distribution Channel, 2026 - 2034
- 8.6.1 Europe Direct Oral Anticoagulants Market, by Distribution Channel, 2026 - 2034 (USD Billion)
- 8.5. Asia Pacific
- 8.5.3 Asia Pacific Direct Oral Anticoagulants Market, 2026 - 2034 (USD Billion)
- 8.5.3.1 Asia Pacific Direct Oral Anticoagulants Market, by Country, 2026 - 2034 (USD Billion)
- 8.5.3 Asia Pacific Direct Oral Anticoagulants Market, 2026 - 2034 (USD Billion)
- 8.4 Asia Pacific Direct Oral Anticoagulants Market, by Drug Type, 2026 - 2034
- 8.4.1 Asia Pacific Direct Oral Anticoagulants Market, by Drug Type, 2026 - 2034 (USD Billion)
- 8.5 Asia Pacific Direct Oral Anticoagulants Market, by Application, 2026 - 2034
- 8.5.1 Asia Pacific Direct Oral Anticoagulants Market, by Application, 2026 - 2034 (USD Billion)
- 8.6 Asia Pacific Direct Oral Anticoagulants Market, by Distribution Channel, 2026 - 2034
- 8.6.1 Asia Pacific Direct Oral Anticoagulants Market, by Distribution Channel, 2026 - 2034 (USD Billion)
- 8.6. Latin America
- 8.6.4 Latin America Direct Oral Anticoagulants Market, 2026 - 2034 (USD Billion)
- 8.6.4.1 Latin America Direct Oral Anticoagulants Market, by Country, 2026 - 2034 (USD Billion)
- 8.6.4 Latin America Direct Oral Anticoagulants Market, 2026 - 2034 (USD Billion)
- 8.4 Latin America Direct Oral Anticoagulants Market, by Drug Type, 2026 - 2034
- 8.4.1 Latin America Direct Oral Anticoagulants Market, by Drug Type, 2026 - 2034 (USD Billion)
- 8.5 Latin America Direct Oral Anticoagulants Market, by Application, 2026 - 2034
- 8.5.1 Latin America Direct Oral Anticoagulants Market, by Application, 2026 - 2034 (USD Billion)
- 8.6 Latin America Direct Oral Anticoagulants Market, by Distribution Channel, 2026 - 2034
- 8.6.1 Latin America Direct Oral Anticoagulants Market, by Distribution Channel, 2026 - 2034 (USD Billion)
- 8.7. The Middle-East and Africa
- 8.7.5 The Middle-East and Africa Direct Oral Anticoagulants Market, 2026 - 2034 (USD Billion)
- 8.7.5.1 The Middle-East and Africa Direct Oral Anticoagulants Market, by Country, 2026 - 2034 (USD Billion)
- 8.7.5 The Middle-East and Africa Direct Oral Anticoagulants Market, 2026 - 2034 (USD Billion)
- 8.4 The Middle-East and Africa Direct Oral Anticoagulants Market, by Drug Type, 2026 - 2034
- 8.4.1 The Middle-East and Africa Direct Oral Anticoagulants Market, by Drug Type, 2026 - 2034 (USD Billion)
- 8.5 The Middle-East and Africa Direct Oral Anticoagulants Market, by Application, 2026 - 2034
- 8.5.1 The Middle-East and Africa Direct Oral Anticoagulants Market, by Application, 2026 - 2034 (USD Billion)
- 8.6 The Middle-East and Africa Direct Oral Anticoagulants Market, by Distribution Channel, 2026 - 2034
- 8.6.1 The Middle-East and Africa Direct Oral Anticoagulants Market, by Distribution Channel, 2026 - 2034 (USD Billion)
- Chapter 9. Company Profiles
- 9.1 Boehringer Ingelheim GmbH
- 9.1.1 Overview
- 9.1.2 Financials
- 9.1.3 Product Portfolio
- 9.1.4 Business Strategy
- 9.1.5 Recent Developments
- 9.2 Johnson & Johnson
- 9.2.1 Overview
- 9.2.2 Financials
- 9.2.3 Product Portfolio
- 9.2.4 Business Strategy
- 9.2.5 Recent Developments
- 9.3 Daiichi Sankyo Company
- 9.3.1 Overview
- 9.3.2 Financials
- 9.3.3 Product Portfolio
- 9.3.4 Business Strategy
- 9.3.5 Recent Developments
- 9.4 Limited
- 9.4.1 Overview
- 9.4.2 Financials
- 9.4.3 Product Portfolio
- 9.4.4 Business Strategy
- 9.4.5 Recent Developments
- 9.5 Pfizer Inc.
- 9.5.1 Overview
- 9.5.2 Financials
- 9.5.3 Product Portfolio
- 9.5.4 Business Strategy
- 9.5.5 Recent Developments
- 9.6 Bristol-Myers Squibb Company
- 9.6.1 Overview
- 9.6.2 Financials
- 9.6.3 Product Portfolio
- 9.6.4 Business Strategy
- 9.6.5 Recent Developments
- 9.7 Gilead Sciences Inc.
- 9.7.1 Overview
- 9.7.2 Financials
- 9.7.3 Product Portfolio
- 9.7.4 Business Strategy
- 9.7.5 Recent Developments
- 9.8 Bayer AG
- 9.8.1 Overview
- 9.8.2 Financials
- 9.8.3 Product Portfolio
- 9.8.4 Business Strategy
- 9.8.5 Recent Developments
- 9.9 Eli Lilly and Company
- 9.9.1 Overview
- 9.9.2 Financials
- 9.9.3 Product Portfolio
- 9.9.4 Business Strategy
- 9.9.5 Recent Developments
- 9.10 GlaxoSmithKline plc
- 9.10.1 Overview
- 9.10.2 Financials
- 9.10.3 Product Portfolio
- 9.10.4 Business Strategy
- 9.10.5 Recent Developments
- 9.11 AstraZeneca PLC
- 9.11.1 Overview
- 9.11.2 Financials
- 9.11.3 Product Portfolio
- 9.11.4 Business Strategy
- 9.11.5 Recent Developments
- 9.12 Sanofi S.A.
- 9.12.1 Overview
- 9.12.2 Financials
- 9.12.3 Product Portfolio
- 9.12.4 Business Strategy
- 9.12.5 Recent Developments
- 9.13 Takeda Pharmaceutical Company Limited
- 9.13.1 Overview
- 9.13.2 Financials
- 9.13.3 Product Portfolio
- 9.13.4 Business Strategy
- 9.13.5 Recent Developments
- 9.14 AbbVie Inc.
- 9.14.1 Overview
- 9.14.2 Financials
- 9.14.3 Product Portfolio
- 9.14.4 Business Strategy
- 9.14.5 Recent Developments
- 9.15 Teva Pharmaceutical Industries Ltd.
- 9.15.1 Overview
- 9.15.2 Financials
- 9.15.3 Product Portfolio
- 9.15.4 Business Strategy
- 9.15.5 Recent Developments
- 9.16 Amgen Inc.
- 9.16.1 Overview
- 9.16.2 Financials
- 9.16.3 Product Portfolio
- 9.16.4 Business Strategy
- 9.16.5 Recent Developments
- 9.17 Roche Holding AG
- 9.17.1 Overview
- 9.17.2 Financials
- 9.17.3 Product Portfolio
- 9.17.4 Business Strategy
- 9.17.5 Recent Developments
- 9.18 Novartis AG
- 9.18.1 Overview
- 9.18.2 Financials
- 9.18.3 Product Portfolio
- 9.18.4 Business Strategy
- 9.18.5 Recent Developments
- 9.19 Merck & Co. Inc.
- 9.19.1 Overview
- 9.19.2 Financials
- 9.19.3 Product Portfolio
- 9.19.4 Business Strategy
- 9.19.5 Recent Developments
- 9.20 Biogen Inc.
- 9.20.1 Overview
- 9.20.2 Financials
- 9.20.3 Product Portfolio
- 9.20.4 Business Strategy
- 9.20.5 Recent Developments
- 9.21 Mylan N.V.
- 9.21.1 Overview
- 9.21.2 Financials
- 9.21.3 Product Portfolio
- 9.21.4 Business Strategy
- 9.21.5 Recent Developments
- 9.22 and others.
- 9.22.1 Overview
- 9.22.2 Financials
- 9.22.3 Product Portfolio
- 9.22.4 Business Strategy
- 9.22.5 Recent Developments
- 9.1 Boehringer Ingelheim GmbH
Table Of Figures
- 1. Market research Type
- 2. Market research methodology
- 3. Global Direct Oral Anticoagulants Market, 2026 - 2034 (USD Billion)
- 4. Porter’s Five Forces Analysis
- 5. Global Direct Oral Anticoagulants Market attractiveness, By Drug Type
- 6. Global Direct Oral Anticoagulants Market attractiveness, By Application
- 7. Global Direct Oral Anticoagulants Market attractiveness, By Distribution Channel
- 8. Global Direct Oral Anticoagulants Market share by Drug Type, 2026 and 2034 (USD Billion)
- 9. Global Direct Oral Anticoagulants Market by Dabigatran, 2026 - 2034 (USD Billion)
- 10. Global Direct Oral Anticoagulants Market by Rivaroxaban, 2026 - 2034 (USD Billion)
- 11. Global Direct Oral Anticoagulants Market by Edoxaban, 2026 - 2034 (USD Billion)
- 12. Global Direct Oral Anticoagulants Market by Apixaban, 2026 - 2034 (USD Billion)
- 13. Global Direct Oral Anticoagulants Market by Others, 2026 - 2034 (USD Billion)
- 14. Global Direct Oral Anticoagulants Market share by Application, 2026 and 2034 (USD Billion)
- 15. Global Direct Oral Anticoagulants Market by Atrial Fibrillation, 2026 - 2034 (USD Billion)
- 16. Global Direct Oral Anticoagulants Market by Pulmonary Embolism, 2026 - 2034 (USD Billion)
- 17. Global Direct Oral Anticoagulants Market by Deep Vein Thrombosis, 2026 - 2034 (USD Billion)
- 18. Global Direct Oral Anticoagulants Market by Others, 2026 - 2034 (USD Billion)
- 19. Global Direct Oral Anticoagulants Market share by Distribution Channel, 2026 and 2034 (USD Billion)
- 20. Global Direct Oral Anticoagulants Market by Hospital Pharmacies, 2026 - 2034 (USD Billion)
- 21. Global Direct Oral Anticoagulants Market by Online Pharmacies, 2026 - 2034 (USD Billion)
- 22. Global Direct Oral Anticoagulants Market by Others, 2026 - 2034 (USD Billion)
- 23. Global Direct Oral Anticoagulants Market share, by Region, 2026 and 2034
- 24. North America Direct Oral Anticoagulants Market, 2026 - 2034 (USD Billion)
- 25. Europe Direct Oral Anticoagulants Market, 2026 - 2034 (USD Billion)
- 26. Asia Pacific Direct Oral Anticoagulants Market, 2026 - 2034 (USD Billion)
- 27. Latin America Direct Oral Anticoagulants Market, 2026 - 2034 (USD Billion)
- 28. The Middle-East and Africa Direct Oral Anticoagulants Market, 2026 - 2034 (USD Billion)
Table Of Tables
- 1. Global Direct Oral Anticoagulants Market: Snapshot
- 2. Drivers of the Direct Oral Anticoagulants Market: impact analysis
- 3. North America Direct Oral Anticoagulants Market revenue, By Drug Type, 2026 - 2034 (USD Billion)
- 4. North America Direct Oral Anticoagulants Market revenue, By Application, 2026 - 2034 (USD Billion)
- 5. North America Direct Oral Anticoagulants Market revenue, By Distribution Channel, 2026 - 2034 (USD Billion)
- 6. U.S. Direct Oral Anticoagulants Market revenue, By Drug Type, 2026 - 2034 (USD Billion)
- 7. U.S. Direct Oral Anticoagulants Market revenue, By Application, 2026 - 2034 (USD Billion)
- 8. U.S. Direct Oral Anticoagulants Market revenue, By Distribution Channel, 2026 - 2034 (USD Billion)
- 9. Canada Direct Oral Anticoagulants Market revenue, By Drug Type, 2026 - 2034 (USD Billion)
- 10. Canada Direct Oral Anticoagulants Market revenue, By Application, 2026 - 2034 (USD Billion)
- 11. Canada Direct Oral Anticoagulants Market revenue, By Distribution Channel, 2026 - 2034 (USD Billion)
- 12. Europe Direct Oral Anticoagulants Market revenue, By Drug Type, 2026 - 2034 (USD Billion)
- 13. Europe Direct Oral Anticoagulants Market revenue, By Application, 2026 - 2034 (USD Billion)
- 14. Europe Direct Oral Anticoagulants Market revenue, By Distribution Channel, 2026 - 2034 (USD Billion)
- 15. Germany Direct Oral Anticoagulants Market revenue, By Drug Type, 2026 - 2034 (USD Billion)
- 16. Germany Direct Oral Anticoagulants Market revenue, By Application, 2026 - 2034 (USD Billion)
- 17. Germany Direct Oral Anticoagulants Market revenue, By Distribution Channel, 2026 - 2034 (USD Billion)
- 18. France Direct Oral Anticoagulants Market revenue, By Drug Type, 2026 - 2034 (USD Billion)
- 19. France Direct Oral Anticoagulants Market revenue, By Application, 2026 - 2034 (USD Billion)
- 20. France Direct Oral Anticoagulants Market revenue, By Distribution Channel, 2026 - 2034 (USD Billion)
- 21. U.K. Direct Oral Anticoagulants Market revenue, By Drug Type, 2026 - 2034 (USD Billion)
- 22. U.K. Direct Oral Anticoagulants Market revenue, By Application, 2026 - 2034 (USD Billion)
- 23. U.K. Direct Oral Anticoagulants Market revenue, By Distribution Channel, 2026 - 2034 (USD Billion)
- 24. Italy Direct Oral Anticoagulants Market revenue, By Drug Type, 2026 - 2034 (USD Billion)
- 25. Italy Direct Oral Anticoagulants Market revenue, By Application, 2026 - 2034 (USD Billion)
- 26. Italy Direct Oral Anticoagulants Market revenue, By Distribution Channel, 2026 - 2034 (USD Billion)
- 27. Spain Direct Oral Anticoagulants Market revenue, By Drug Type, 2026 - 2034 (USD Billion)
- 28. Spain Direct Oral Anticoagulants Market revenue, By Application, 2026 - 2034 (USD Billion)
- 29. Spain Direct Oral Anticoagulants Market revenue, By Distribution Channel, 2026 - 2034 (USD Billion)
- 30. Rest of Europe Direct Oral Anticoagulants Market revenue, By Drug Type, 2026 - 2034 (USD Billion)
- 31. Rest of Europe Direct Oral Anticoagulants Market revenue, By Application, 2026 - 2034 (USD Billion)
- 32. Rest of Europe Direct Oral Anticoagulants Market revenue, By Distribution Channel, 2026 - 2034 (USD Billion)
- 33. Asia Pacific Direct Oral Anticoagulants Market revenue, By Drug Type, 2026 - 2034 (USD Billion)
- 34. Asia Pacific Direct Oral Anticoagulants Market revenue, By Application, 2026 - 2034 (USD Billion)
- 35. Asia Pacific Direct Oral Anticoagulants Market revenue, By Distribution Channel, 2026 - 2034 (USD Billion)
- 36. China Direct Oral Anticoagulants Market revenue, By Drug Type, 2026 - 2034 (USD Billion)
- 37. China Direct Oral Anticoagulants Market revenue, By Application, 2026 - 2034 (USD Billion)
- 38. China Direct Oral Anticoagulants Market revenue, By Distribution Channel, 2026 - 2034 (USD Billion)
- 39. Japan Direct Oral Anticoagulants Market revenue, By Drug Type, 2026 - 2034 (USD Billion)
- 40. Japan Direct Oral Anticoagulants Market revenue, By Application, 2026 - 2034 (USD Billion)
- 41. Japan Direct Oral Anticoagulants Market revenue, By Distribution Channel, 2026 - 2034 (USD Billion)
- 42. India Direct Oral Anticoagulants Market revenue, By Drug Type, 2026 - 2034 (USD Billion)
- 43. India Direct Oral Anticoagulants Market revenue, By Application, 2026 - 2034 (USD Billion)
- 44. India Direct Oral Anticoagulants Market revenue, By Distribution Channel, 2026 - 2034 (USD Billion)
- 45. South Korea Direct Oral Anticoagulants Market revenue, By Drug Type, 2026 - 2034 (USD Billion)
- 46. South Korea Direct Oral Anticoagulants Market revenue, By Application, 2026 - 2034 (USD Billion)
- 47. South Korea Direct Oral Anticoagulants Market revenue, By Distribution Channel, 2026 - 2034 (USD Billion)
- 48. South-East Asia Direct Oral Anticoagulants Market revenue, By Drug Type, 2026 - 2034 (USD Billion)
- 49. South-East Asia Direct Oral Anticoagulants Market revenue, By Application, 2026 - 2034 (USD Billion)
- 50. South-East Asia Direct Oral Anticoagulants Market revenue, By Distribution Channel, 2026 - 2034 (USD Billion)
- 51. Rest of Asia Pacific Direct Oral Anticoagulants Market revenue, By Drug Type, 2026 - 2034 (USD Billion)
- 52. Rest of Asia Pacific Direct Oral Anticoagulants Market revenue, By Application, 2026 - 2034 (USD Billion)
- 53. Rest of Asia Pacific Direct Oral Anticoagulants Market revenue, By Distribution Channel, 2026 - 2034 (USD Billion)
- 54. Latin America Direct Oral Anticoagulants Market revenue, By Drug Type, 2026 - 2034 (USD Billion)
- 55. Latin America Direct Oral Anticoagulants Market revenue, By Application, 2026 - 2034 (USD Billion)
- 56. Latin America Direct Oral Anticoagulants Market revenue, By Distribution Channel, 2026 - 2034 (USD Billion)
- 57. Brazil Direct Oral Anticoagulants Market revenue, By Drug Type, 2026 - 2034 (USD Billion)
- 58. Brazil Direct Oral Anticoagulants Market revenue, By Application, 2026 - 2034 (USD Billion)
- 59. Brazil Direct Oral Anticoagulants Market revenue, By Distribution Channel, 2026 - 2034 (USD Billion)
- 60. Mexico Direct Oral Anticoagulants Market revenue, By Drug Type, 2026 - 2034 (USD Billion)
- 61. Mexico Direct Oral Anticoagulants Market revenue, By Application, 2026 - 2034 (USD Billion)
- 62. Mexico Direct Oral Anticoagulants Market revenue, By Distribution Channel, 2026 - 2034 (USD Billion)
- 63. Rest of Latin America Direct Oral Anticoagulants Market revenue, By Drug Type, 2026 - 2034 (USD Billion)
- 64. Rest of Latin America Direct Oral Anticoagulants Market revenue, By Application, 2026 - 2034 (USD Billion)
- 65. Rest of Latin America Direct Oral Anticoagulants Market revenue, By Distribution Channel, 2026 - 2034 (USD Billion)
- 66. The Middle-East and Africa Direct Oral Anticoagulants Market revenue, By Drug Type, 2026 - 2034 (USD Billion)
- 67. The Middle-East and Africa Direct Oral Anticoagulants Market revenue, By Application, 2026 - 2034 (USD Billion)
- 68. The Middle-East and Africa Direct Oral Anticoagulants Market revenue, By Distribution Channel, 2026 - 2034 (USD Billion)
- 69. GCC Countries Direct Oral Anticoagulants Market revenue, By Drug Type, 2026 - 2034 (USD Billion)
- 70. GCC Countries Direct Oral Anticoagulants Market revenue, By Application, 2026 - 2034 (USD Billion)
- 71. GCC Countries Direct Oral Anticoagulants Market revenue, By Distribution Channel, 2026 - 2034 (USD Billion)
- 72. South Africa Direct Oral Anticoagulants Market revenue, By Drug Type, 2026 - 2034 (USD Billion)
- 73. South Africa Direct Oral Anticoagulants Market revenue, By Application, 2026 - 2034 (USD Billion)
- 74. South Africa Direct Oral Anticoagulants Market revenue, By Distribution Channel, 2026 - 2034 (USD Billion)
- 75. Rest of Middle-East Africa Direct Oral Anticoagulants Market revenue, By Drug Type, 2026 - 2034 (USD Billion)
- 76. Rest of Middle-East Africa Direct Oral Anticoagulants Market revenue, By Application, 2026 - 2034 (USD Billion)
- 77. Rest of Middle-East Africa Direct Oral Anticoagulants Market revenue, By Distribution Channel, 2026 - 2034 (USD Billion)
Methodology
FrequentlyAsked Questions
Direct Oral Anticoagulants (DOACs) are a class of oral anticoagulants that function to prevent and treat blood clots via direct inhibition of one or more than one clotting factors responsible for the formation of the blood clots.
The direct oral anticoagulants market is primarily driven by the rising prevalence of atrial fibrillation and venous thromboembolism, increasing preference for DOACs over traditional anticoagulants due to their predictable efficacy and reduced need for routine monitoring, and the growing global aging population.
The direct oral anticoagulants market faces several growth challenges, including the high cost of treatment compared with traditional anticoagulants, which limits adoption in cost-sensitive markets, and increasing competition from generic products, which puts pressure on pricing and revenues.
Based on the application, the atrial fibrillation segment is expected to dominate the direct oral anticoagulants market growth during the projected period.
Key emerging trends and innovations in the direct oral anticoagulants market include the expansion of approved indications, increasing use in special patient populations such as pediatric and cancer-associated thrombosis patients, and the growing adoption of personalized anticoagulation strategies.
According to the report, the global direct oral anticoagulants market size was worth around USD 19.8 billion in 2025 and is predicted to grow to around USD 41.3 billion by 2034.
The global direct oral anticoagulants market is expected to grow at a CAGR of 8.5% during the forecast period.
The global direct oral anticoagulants industry growth is expected to be led by North America over the forecast period.
The global direct oral anticoagulants market is dominated by players like Boehringer Ingelheim GmbH, Johnson & Johnson, Daiichi Sankyo Company, Limited, Pfizer Inc., Bristol-Myers Squibb Company, Gilead Sciences, Inc., Bayer AG, Eli Lilly and Company, GlaxoSmithKline plc, AstraZeneca PLC, Sanofi S.A., Takeda Pharmaceutical Company Limited, AbbVie Inc., Teva Pharmaceutical Industries Ltd., Amgen Inc., Roche Holding AG, Novartis AG, Merck & Co., Inc., Biogen Inc., and Mylan N.V., among others.
The direct oral anticoagulants market report covers the geographical market along with a comprehensive competitive landscape analysis. It also includes cash flow analysis, profit ratio analysis, market basket analysis, market attractiveness analysis, sentiment analysis, PESTLE analysis, trend analysis, SWOT analysis, trade area analysis, demand & supply analysis, Porter’s five forces analysis, and value chain analysis.
HappyClients
